Two Sigma Investments
NEO icon

Two Sigma Investments’s NeoGenomics NEO Stock Holding History

Two Sigma Investments’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,200
Closed -$396K – 4660
2021
Q3 		$396K Sell
8,200
-600
-7% -$27.8K ﹤0.01% 3448
2021
Q2 		$397K Buy
8,800
+1,400
+19% +$62K ﹤0.01% 3289
2021
Q1 		$357K Buy
+7,400
New +$385K ﹤0.01% 3204

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Two Sigma Investments's NEO Position: Q1 2026 in Review

Two Sigma Investments sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 170,900 shares — an estimated $2.01M sold.

Two Sigma Investments first reported a position in NEO in Q3 2014 and held it in 19 quarters. The position peaked at $11.9M in Q2 2022. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Two Sigma Investments reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 170,900 NeoGenomics shares in Q1 2026, an estimated $2.01M.
  • Two Sigma Investments first reported a position in NeoGenomics in Q3 2014 and held it in 19 quarters.
  • Two Sigma Investments's NeoGenomics position peaked at $11.9M in Q2 2022.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.